title: Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs.
abstract: Hyperlipemic serum and plasma samples often are received by clinical laboratories for endocrinologic analysis by radioimmunoassay. We designed a study to determine what effect, if any, hyperlipemia has on estimation of lipid-soluble hormone concentrations determined by solid-phase radioimmunoassays. Progesterone, testosterone, thyroxine, and cortisol concentrations were determined in canine plasma and serum with various degrees of lipemia. Samples of serum, heparinized plasma, and EDTA-treated plasma were obtained from blood collected from 4 female and 4 male Beagles by use of evacuated tubes. To induce hyperlipemia in vitro, IV fat emulsion was diluted in deionized water to produce 0 (water only), 33, 67, or 100% mixtures. Twenty microliters of each mixture then was added to the subsamples of serum and plasma from each dog. Hormone concentrations were determined, using validated radioimmunoassays. Triglyceride concentrations were determined by enzymatic assay. Addition of IV fat emulsion in vitro was an accurate and reproducible means of altering triglyceride concentrations in the samples. Triglyceride concentrations as high as 700 mg/dl had no effect on radioimmunoassays for progesterone, testosterone, and thyroxine in serum, heparinized plasma, or EDTA-treated plasma. Addition of 100% (but not 33 or 67%) fat emulsion reduced the mean cortisol concentration in heparinized plasma by 12% (P less than 0.05). This severe hyperlipemia did not affect quantification of cortisol in serum or EDTA-treated plasma.
authors.affiliation: Diagnostic Laboratory, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
authors.forename: D E
authors.initials: DE
authors.lastname: Lee
authors.forename: S V
authors.initials: SV
authors.lastname: Lamb
authors.forename: T J
authors.initials: TJ
authors.lastname: Reimers
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000097:blood*; D004285:Dogs; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood*; D006854:Hydrocortisone / Q000097:blood*; D006949:Hyperlipidemias / Q000097:blood / Q000662:veterinary*; D008297:Male; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D012044:Regression Analysis; D013739:Testosterone / Q000097:blood; D013974:Thyroxine / Q000097:blood*; D014280:Triglycerides / Q000097:blood
chemical_list: D005217:Fat Emulsions, Intravenous; D012739:Gonadal Steroid Hormones; D014280:Triglycerides; D013739:Testosterone; D011374:Progesterone; D013974:Thyroxine; D006854:Hydrocortisone